VolitionRx Overview

  • Founded

  • 1998

Founded
  • Status

  • Public

  • Employees

  • 83

Employees
  • Stock Symbol

  • VNRX

Stock Symbol
  • Investments

  • 4

  • Share Price

  • $2.03

  • (As of Friday Closing)

VolitionRx General Information

Description

VolitionRX Ltd is a us-based multi-national life sciences company. It is engaged in developing easy to use blood-based tests to accurately diagnose a range of cancers. The development pipeline includes assays to be used for symptomatic patients or asymptomatic populations. The company has developed more than 30 blood-based assays to detect specific biomarkers. It also develops Nucleosomics tests for several major cancers including CRC, pancreatic, lung and aggressive prostate. In addition, the company engages in the process of developing HyperGenomics tissue and blood-based tests to determine disease subtype following initial diagnosis and to help decide the appropriate therapy.

Contact Information

Website
www.volition.com
Formerly Known As
Standard Capital
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
ASE
Primary Office
  • 1 Scotts Road
  • No 24-05 Shaw Centre
  • Singapore, 228208
  • Singapore

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VolitionRx Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.03 $2.05 $1.85 - $4.14 $115M 56.8M 76.1K -$0.52

VolitionRx Financials Summary

In Thousands,
USD 		TTM 31-Mar-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 145,077 148,693 170,049 178,301
Revenue 179 90 13 17
EBITDA (27,271) (25,692) (19,278) (15,182)
Net Income (28,333) (26,815) (20,352) (16,099)
Total Assets 31,683 27,490 26,151 21,291
Total Debt 4,742 4,017 4,442 3,938
Public Fundamental Data provided by Morningstar, Inc. disclaimer

VolitionRx Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore VolitionRx‘s full profile, request access.

Request a free trial

VolitionRx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
VolitionRX Ltd is a us-based multi-national life sciences company. It is engaged in developing easy to use blood-based t
Biotechnology
Singapore, Singapore
83 As of 2021
000.00
000000000 000.00

000000

dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur si
0000000000000
Mont-Saint-Guibert, Belgium
000 As of 0000
00000
000000000 00000

000000

xercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repreh
0000000000000
Cambridge, MA
000 As of 0000
00000
0.000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

VolitionRx Competitors (37)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Celyad Oncology Formerly VC-backed Mont-Saint-Guibert, Belgium 000 00000 000000000 00000
000000 0000000 000 Formerly VC-backed Cambridge, MA 000 00000 000000&0 00000
0000 0000 00000000 Angel-Backed West Palm Beach, FL 00.000 0000000000 00.000
00000000 Private Debt Financed Hayward, CA 00 000000000 -
0000 00000000000 Formerly VC-backed Cambridge, MA 00 00000 00000000 00000
You’re viewing 5 of 37 competitors. Get the full list »

VolitionRx Executive Team (12)

Name Title Board Seat Contact Info
Gaetan Michel Ph.D Chief Operating Officer
Cameron Reynolds Chief Executive Officer & Board Member
Jasmine Kway Ph.D Chief Executive Officer
David Vanston Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Terig Hughes Chief Financial Officer
You’re viewing 5 of 12 executive team members. Get the full list »

VolitionRx Board Members (8)

Name Representing Role Since
0000 000000 00.0 VolitionRx Board Member 000 0000
0000000 00000000 VolitionRx Chief Executive Officer & Board Member 000 0000
000000 0000000 00.0 VolitionRx Board Member 000 0000
000 00000 VolitionRx Board Member 000 0000
000 000000 VolitionRx Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

VolitionRx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VolitionRx Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 (0000 10-Jan-2020 0000000000 00000 Drug Delivery 0000000 0
000000 000000 24-Feb-2015 000000000 Buildings and Property 0000000 0
000000000 000 06-Oct-2011 0000000000 000.00 Other Commercial Products 000 00000
Plures Technologies 15-Mar-2011 Merger/Acquisition Application Specific Semiconductors
To view VolitionRx’s complete investments and acquisitions history, request access »

Ready to get started?

Request a free trial

VolitionRx Subsidiaries (1)

Company Name Industry Location Founded
0000000 (0000000) Drug Delivery Grafelfing, Germany
To view VolitionRx’s complete subsidiaries history, request access »